⌘K

Login Start Free

Home/Filings/6-K/0001213900-25-105591

6-K//Foreign company update

KAMADA LTD 6-K

Accession 0001213900-25-105591

$KMDACIK 0001567529other

View on SEC.gov Company Profile

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 7:00 AM ET

Size

25.7 KB

Accession

0001213900-25-105591

Documents

2 files

6-K
ea0263587-6k_kamada.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea026358701ex99-1_kamada.htm
KAMADA ANNOUNCES FIRST PATIENT ENROLLED INTO AN INVESTIGATOR-INITIATED CLINICAL TRIAL OF CYTOGAM TO PREVENT CYTOMEGALOVIRUS IN KIDNEY TRANSPLANTATION

Issuer

KAMADA LTD

CIK 0001567529

Entity typeother

IncorporatedIsrael

Related Parties

1

filerCIK 0001567529

Filing Metadata

Form type: 6-K
Filed: Nov 3, 7:00 PM ET
Accepted: Nov 4, 7:00 AM ET
Size: 25.7 KB

View on SEC.gov